New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For MSFT;GOOG;AAPL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | all recent news | >>
April 27, 2015
08:06 EDTAAPLApple Q2 revenue likely to surpass guidance, says RBC Capital
RBC Capital says that Apple's Q2 revenue should come in above the high end of its $52B-$55B guidance. The firm thinks the company's gross margins could beat expectations, and it keeps an Outperform rating on the shares.
07:13 EDTGOOG, MSFTUBM Tech to hold a conference
Subscribe for More Information
07:00 EDTAAPLFutures higher as investors prepare for more earnings reports
Subscribe for More Information
06:31 EDTAAPLApple may be intentionally slowing release of Tidal app updates, NY Post says
Subscribe for More Information
06:01 EDTGOOGGoogle's Dan Fredinburg dies in avalanche on Mount Everest, TechCrunch reports
Subscribe for More Information
05:58 EDTGOOGeBay backs Google's response to EU antitrust inquiry, Financial Times says
Subscribe for More Information
05:31 EDTAAPLApple initiated with a Buy, $160 target at Brean Capital
Brean Capital analyst Ananda Baruah initiated shares of Apple with a Buy rating and $160 price target ahead of the company's March quarter results tonight. Baruah tells investors that consensus estimates for the iPhone maker are "materially low" though 2017. The analyst sees upside through 2017 from iPhone shipments and favorable gross margin due to greater than expected sales of the more profitable 6 Plus. Shares of Apple closed Friday up 61c to $130.28.
April 26, 2015
12:50 EDTAAPLApple, Celgene, others are 'top picks' for spring, Barron's says
In a survey of U.S. money managers, shares of Apple (AAPL), Dow Chemical (DOW), American Airlines (AAL), Celgene (CELG), General Motors (GM), and McDermott (MDR) were identified as top picks for this spring, Barron's contends in its cover story. Reference Link
April 24, 2015
18:27 EDTAAPLTD Bank Group announces Apple Watch app
Subscribe for More Information
16:31 EDTGOOG, MSFTStocks finish week higher following strong tech earnings
Subscribe for More Information
16:19 EDTMSFT, GOOGOn The Fly: Top stock stories for Friday
Subscribe for More Information
16:00 EDTMSFT, AAPL, GOOGOptions Update; April 24, 2015
iPath S&P 500 VIX Short-Term Futures down 21c to 20.89. Option volume leaders: AAPL AMZN PBR RIG GOOG TWTR TSLA MSFT ALTR according to Track Data.
14:50 EDTAAPLOn The Fly: Weekly technical notes ahead of Apple earnings
Subscribe for More Information
13:45 EDTAAPLGrubHub launches Seamless App for Apple Watch
Subscribe for More Information
12:53 EDTGOOGLuxottica says company working on new versions of Google Glass, Engadget says
Subscribe for More Information
12:49 EDTGOOG, MSFTOn The Fly: Top stock stories at midday
Subscribe for More Information
12:33 EDTAAPLOptions with increasing implied volatility
Options with increasing implied volatility: MEMP GPRO TWTR AAPL
10:00 EDTMSFTOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AT&T (T) upgraded to Outperform from Neutral at Macquarie... Alaska Air (ALK) upgraded to Buy from Neutral at Buckingham... Amazon.com (AMZN) upgraded at Raymond James... American Electric (AEP) upgraded to Buy from Hold at Deutsche Bank... Broadridge (BR) upgraded to Buy from Hold at Evercore ISI... Cablevision (CVC) upgraded to Hold from Sell at Brean Capital... Cisco (CSCO) upgraded to Conviction Buy from Buy at Goldman... Core Laboratories (CLB) upgraded to Outperform from Sector Perform at Iberia... Crown Castle (CCI) upgraded to Outperform from Market Perform at Raymond James... Encore Wire (WIRE) upgraded to Buy from Neutral at Sidoti... Gigamon (GIMO) upgraded to Buy from Neutral at DA Davidson... Juniper (JNPR) upgraded on improved outlook at RBC Capital... KPN (KKPNY) upgraded to Buy from Neutral at Goldman... Knight Transportation (KNX) upgraded to Outperform from Market Perform at Avondale... Mattel (MAT) upgraded to Buy from Neutral at Goldman... Microsoft (MSFT) upgraded to Buy from Neutral at Nomura... Premiere Global (PGI) upgraded to Outperform from Market Perform at Raymond James... Quintiles (Q) upgraded to Buy from Hold at Jefferies... Southwestern Energy (SWN) upgraded to Market Perform at Raymond James... TE Connectivity (TEL) upgraded on positive catalysts at SunTrust... Target (TGT) upgraded to Buy from Neutral at BofA/Merrill... TriState Capital (TSC) upgraded to Overweight from Equal Weight at Stephens... United Continental (UAL) upgraded to Buy from Hold at Evercore ISI... Vipshop (VIPS) upgraded to Buy from Hold at HSBC... Vocera (VCRA) upgraded to Buy from Hold at Craig-Hallum.
09:37 EDTMSFT, AAPL, GOOGActive equity options trading on open
Subscribe for More Information
09:20 EDTMSFT, GOOGOn The Fly: Pre-market Movers
UP AFTER EARNINGS: eHealth (EHTH), up 24.7%... Starbucks (SBUX), up 4.2%... Microsoft (MSFT), up 5.2%... Google (GOOG, GOOGL), up 3.2% and up 3.7%, respectively... Amazon (AMZN), up 12% after reporting quarterly results and announcing shopping app for Apple Watch... Gigamon (GIMO), up 16.5%... Juniper Networks (JNPR), up 6.6%. ALSO HIGHER: Molycorp (MCP), up 10.2% following a Bloomberg report that China's export tax decision may boost rare earth demand... Mattel (MAT), up 4.4% after being upgraded to Buy from Neutral at Goldman... Innocoll (INNL), up 13.1% after 3.3M share Secondary priced at $9.00... Cytosorbents (CTSO), up 9.7% after CEO comments on CytoSorb in letter to shareholders. DOWN AFTER EARNINGS: Biogen (BIIB), down 4.7%... Altera (ALTR), down 1.7%... Pandora (P), down 4%... ResMed (RMD), down 8.7%... Xerox (XRX), down 4.7%... HomeAway (AWAY), down 3.6% after reporting quarterly results and departure of officers. ALSO LOWER: Ubiquiti (UBNT), down 14.4% following CFO resignation and preliminary third quarter results... 3D Systems (DDD), down 10.4% after reporting preliminary first quarter results... StemCells (STEM), down 23.2% after filing to sell common stock... Aerie Pharmaceuticals (AERI), down 54.7% after Rhopressa Phase 3 trial did not meet primary endpoint.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use